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Cardiac stem cells represent a logical cell type to exploit in cardiac regeneration. The eﬃcient harvest of cardiac stem cells from a
suitable source would turn promising in cardiac stem cell therapy. Brown adipose was recently found to be a new source of cardiac
stem cells, instrumental to myocardial regeneration. Unfortunately, an eﬃcient method for the cell isolation is unavailable so far.
In our study we have developed a new method for the eﬃcient isolation of cardiac stem cells from brown adipose by combining
diﬀerent enzymes. Results showed that the total cell yield dramatically increased (more than 10 times, P<. 01) compared with that
by previous method. The content of CD133-positive cells (reported to diﬀerentiate into cardiomyocytes with a high frequency)
was much higher than that in the previous report (22.43% versus 3.5%). Moreover, the isolated cells could be the eﬃciently
diﬀerentiated into functional cardiomyocytes in optimized conditions. Thus, the new method we established would be of great use
in further exploring cardiac stem cell therapy.
1.Introduction
Despite the notion that adult hearts are terminally diﬀer-
entiated organs without self-renewal potential undermined
by the discovery of resident cardiac stem/progenitor cells,
the endogenous regenerative mechanisms are too limited
to suﬃciently compensate for the cardiomyocytes loss
occurring in pathological state (e.g., myocardial infarction)
[1–3]. This led to numerous investigations to identify a
putative source of new cardiomyocytes to ameliorate the
injured myocardium and improve the cardiac function. Stem
cells, capable of diﬀerentiating into other cell types, that is,
functional cardiomyocytes, have intrigued intensive studies.
So far various stem cell sources have been explored for
myocardial regeneration, including embryonic stem, skeletal
myoblasts, bone marrow mesenchymal stem cells [4–7].
Data demonstrated functional improvement of the infarcted
heart by transplanting these cells. However, the cells also
have shortfalls, for example, the potential of tumorigenicity
with embryonic stem cells, arrhythmogenicity with skeletal
myoblasts, and the controversial transdiﬀerentiation of bone
marrow-derived stem cells [8]. These problems underscore
the need to search for new sources of adult stem cells to
generate cardiomyocytes against the failing myocardium.
The identiﬁcation and isolation of cardiac stem cells
(CSCs)reignitedtheexcitementinthisﬁeld[3,9,10].Diﬀer-
ent from other adult stem cells, cardiac stem cells represent a
logical source to exploit in myocardial regeneration because
oftheirlikelihoodtobeintrinsicallyprogrammedtogenerate
cardiac tissues in vitro and increase its viability in vivo.
Therefore, the cardiac stem cell therapy may pioneer an
innovative approach to treat heart diseases [11]. However,
technical diﬃculties exist in collecting the cells at present.
The number of cells upon harvest is too low [12, 13].
Therefore, it would be appealing to search for an alternative
source of cardiac stem cells.
Adipose tissues are abundant in mammals. Once suc-
cessfully explored, the tissue source would have far-reaching
eﬀects in regenerative medicine [14, 15]. Therefore, adipose-
derived cells were also extensively investigated as candidates
for the myocardial regeneration by many groups [16, 17].
Planat-B´ enard et al. ﬁrst reported the spontaneous diﬀeren-
tiation of murine adipose-derived cells into cardiomyocytes
in 2004 [1]. In spite of its rather low rate (0.02% to 0.07%),2 Journal of Biomedicine and Biotechnology
the cardiomyogenic diﬀerentiation suggested that adipose
tissue may provide a new source for cardiac progenitor/stem
cells. The subsequent studies by Yamada et al. further
demonstrated that the cardiac diﬀerentiation was far more
eﬃcient in brown adipose-derived cells ( 20%) than that
described by Planat-B´ enard [1, 12]. They have proved brown
adipose to be an abundant source of cardiac stem cells.
The discovery of the cardiac stem cells in brown adi-
pose opened a new channel to provide cardiomyocytes for
myocardial regeneration. However, the previous methods
[1, 12] for cell isolation are ineﬀective. In the present study,
we developed a new method to isolate brown adipose-
derived cardiac stem cells with great eﬃciency by combining
collagenase IV and dispase II, with trypsin. The optimized
isolation and diﬀerentiation of obtained cells were detailed.
Moreover,thecardiomyogeniceﬃciencyofisolatedcellswith
this new method was also evaluated.
2.MaterialsandMethods
2.1. Animals and Tissue Samples. A l la n i m a l sw e r ep u r c h a s e d
from the Experimental Animal Center, Academy of Military
Medical Science (Beijing, China). The Institutional Animal
Care and Use Committee (IACUC) of the Chinese Academy
of Military Medical Science, Beijing, China, approved all
experiments in this study. To obtain tissue samples, animals
were killed by intraperitoneally injecting with overdose
sodium pentobarbital. The brown adipose tissue was derived
frominterscapularof neonatal SD rats (Postnatal7–14 days).
Every eﬀort was made to minimize animal suﬀering and the
number of animals used.
2.2. Cell Isolation from Rat Brown Adipose. Isolated
brown adipose tissues were washed extensively with sterile
phosphate-buﬀered saline (PBS) to remove contaminating
debris and red blood cells. Then it was minced with scissors
and digested with 0.1% collagnase IV (m/v, Sigma), 0.1%
dispase II (m/v, Roche Diagnostics, Mannheim, Germany)
and 0.05% trypsin (m/v, Sigma) in serum-free medium.
The digestion was performed at 37
◦C for 30–60 minutes
with gentle agitation. Then, the enzymes were inactivated
with an equal volume of α-MEM/10% fetal bovine serum
(FBS, Gibco) and the samples were ﬁltered through a 75-μm
mesh ﬁlter to remove debris. The cellular pellets were
resuspended in α-MEM/10% fetal bovine serum (FBS); red
cell lysis buﬀer was added. After a 5-minute lysis period,
cells were centrifuged and resuspended. Nucleated cells
were counted for cell yield. Then cells were plated onto
conventional culture plates and cultured under 37
◦C, 5%
CO2 conditions. For cell viability determination, a portion
of cells were stained with propidiumiodide (PI) and analyzed
by ﬂow cytometry.
2.3. Flow Cytometry Analysis. For ﬂow cytometry, the newly
isolated stromal cells from brown adipose were lyzed
by red cell lysis buﬀer as described above. Then, cells
were harvested for ﬂow cytometry analysis as previously
described [18]. Brieﬂy, cells were ﬁxed for 30 minutes in
ice-cold 2% paraformaldehyde. The ﬁxed cells were washed
in ﬂow cytometry buﬀer (FBS, Biolegend, 420201) and
incubated for 30 minutes in FBS containing the following
antibodies: ﬂuorescein isothiocyanate-conjugated antiCD90
(Biolegend, 202503), phycoerythrin-conjugated antiCD29
(Biolegend,102221), FITC-conjugated antiCD45 (Biolegend,
202205), FITC-conjugated CD34 (Santa Cruze, sc-7324),
as well as CD133 (Santa Cruze, sc-32596). For unlabelled
primary antibodies, FITC-conjugated secondary antibodies
were added. All analyses were performed using a BD ﬂow
cytometer (BD Bioscience, San Jose, CA).
2.4. Diﬀerentiating CSCs into Cardiomyocytes. CSCs from
brown adipose have the potential to spontaneously diﬀeren-
tiate into functional cardiomyocytes as previously reported
[12].Todeterminetheoptimalseedingdensityforcardiomy-
ocytes diﬀerentiation, primary stromal cells were seeded
onto culture plates at diﬀerent densities, ranging from 2.5 ×
103 to 8 × 104 cells/cm2. The cells were incubated in 37
◦C,
5% CO2 for culture and diﬀerentiation. The medium was
changed every 2 days. Cells of diﬀerent seeding densities
were observed every day under an inverted phase-contrast
microscope (IX70 inverted system microscopy, Olympus
Optical, Melville, NY). Number as well as morphology of
developing clones was recorded.
2.5. Immunohistochemistry. To investigate the expression of
cardiac speciﬁc antigens in the CSC-derived cardiomyocytes,
immunohistochemical analyses on slides with elongated
clusters of cells [19]. Brieﬂy, isolated cells from brown
adipose were seeded on slides. The cells were cultured and
diﬀerentiated for 3-4w as described above. Then, diﬀer-
entiated cells grown in slides were washed and ﬁxed with
4% paraformaldehyde in 0.1M phosphate buﬀer (pH 7.4).
Afterpermeabilizationwith0.1%TritonX-100,thecellswere
incubated with the primary antibody against cTnT (diluted
1:200, Sigma) and α-sarcomeric actinin (diluted 1:200;
Sigma) overnight at 4◦C. FITC-labeled goat antimouse IgG
was used as the secondary antibody. The cells were incubated
with Hoechst33258 for genomic DNA staining and observed
under a ﬂuorescent microscope (Olympus Optical, Melville,
NY).
2.6. Pharmacological Studies. Diﬀerentiated cells with a
regular contractile activity were selected. The basal beating
rate was recorded before and after the replacement of culture
medium by the fresh αMEM medium (Gibco) containing
10% of fetal bovine serum. Chronotropic responses were
then assessed in αMEM/10%FBS by extra-cellular recording
of the beating rate in the presence of the appropriate drugs.
Dose-response experiments were performed with 0.25 to
5 × 10
−6μmol/L isoproterenol and 5 to 10 × 10
−6 μmol/L
dilthiazem. Antagonist was added after the maximal dose of
agonist. The values were represented as mean ± SD.
2.7. RNA Extraction and RT-PCR Analysis. For RNA extrac-
tion, elongated clusters of cells were dissected under an
inverted phase-contrast microscope as previous report [20].Journal of Biomedicine and Biotechnology 3
Table 1: Correlation between digest time and cell yield when
diﬀerent enzymes were used for brown adipose digest.
Digest time—Cell yield
Time Enzyme∗ Cell yield$ Cell viability Viable cell yield$
30 minutes
D/IV/T 8.49 ± 0.57 93.47±1.18% 7.94±0.58
IV/T 2.74±0.39 93.79±1.22% 2.57±0.39
IV 1.47±0.19 94.66±0.99% 1.39±0.18
I0 . 1 8 ±0.02 93.95±1.05% 0.17±0.02
D0 . 7 8 ±0.07 94.96±0.88% 0.74±0.07
45 minutes
D/IV/T 11.65±1.07 90.72±1.38% 10.56±0.98#
IV/T 4.26±0.56 91.87±1.34% 3.92±0.54
IV 1.82±0.20 92.87±1.69% 1.69±0.20
I0 . 2 3 ±0.04 91.96±0.77% 0.22±0.04
D0 . 8 7 ±0.06 93.18±1.36% 0.81±0.07
60 minutes
D/IV/T 11.72±0.86 86.88±1.50% 10.19±0.91
IV/T 4.66±0.33 90.86±1.45% 4.23±0.31#
IV 1.96±0.15 91.17±1.55% 1.79±0.14#
I0 . 2 8 ±0.04 90.10±1.14% 0.26±0.04#
D1 . 0 2 ±0.13 91.14±1.57% 0.93±0.12#
Nucleated cell yields of cell viability were compared among diﬀerent
enzymes and diﬀerent digest time. Data are presented as mean ± standard
deviation of n=6f o re a c hg r o u p .
∗D Dispase II; IV: collagenase IV; T: trypsin; I: collagenase I;
#Optimal cell yield for the enzyme.
$106 cells/g tissue.
Total RNA was extracted with RNAprep pure Cell/Bacteria
Kit (TIANGEN) according to manufacturer’s instruction.
Reverse transcription were performed using standard pro-
cedures to synthesize ﬁrst-strand cDNA. The gene-speciﬁc
primers for cTnI (5 -CTCGGAGTATCAGGAAGAGCACA;
3 -TAAACTTGCCACGCAGGTCATAG, 216bp), GATA4
(5  -CTGTCATCTCACTATGGGCA;3 -CCAAGTCCG-
AGCAGGAATT, 257bp), Nkx2.5 (5 -CAGTGGAGCTGG-
ACAAAGCC; 3 -TAGCGACGGTTCTGGAACCA, 216bp),
MEF2C (5 -AGCAAGAATACGATGCCATC; 3 -GAAGGG-
GTGGTGGTACGGTC, 347bp), β-Actin (5 -AGAGGG-
AAATCGTGCGTGAC; 3 -AGGAGCCAGGCAGTAATC,
353bp) were used in the following PCR ampliﬁcation. Each
cycle consisted of denaturation at 94
◦C for 30 secondes, and
annealing/extension at 72
◦C for 45 secondes.
2.8. Statistical Analysis. The data are reported as
means±SD. Multiple related samples were compared using
the Friedman test, results of which were complemented with
posthoc pairwise analysis by Wilcoxon signed-rank test.
Statistical analyses was performed with SPSS 11.0 (SPSS,
Inc., Chicago, IL). Signiﬁcance was accepted at P<. 05.
3. Results
3.1. Optimized Isolation and High Cell Yield. To optimize
isolating conditions for cell yield as high as possible, tissue
digest was performed in 37
◦C, 5% CO2 incubator. The
correlation between digesting time and cell yield was inves-
tigated, so did cell viability. Comparisons have been made
Table 2: Phenotypic characterization of rat brown adipose-derived
cells (n = 6).
Surface marker Positive cells (%)
CD90 54.82±3.50
CD133 22.43±2.13
CD29 18.23±1.97
CD29/CD133 8.22±1.11
CD45 2.09±0.72
CD34 0.12±0.05
against the established method to isolate brown adipose-
derived cardiac progenitor/stem cells with Dispase II and
the classic one for stromal cell isolation from adipose tissue
with collagenase I. In addition, other collagenases beside
collagenase I were also tried. Collagenase IV was found
more eﬃcient than collagenase I for rat adipose digest
(Table 1, Figure 1(a)). Thus, collagenase IV was selected for
the enzyme combination in the experiment ensued. Data
show that cell yield was up to7.94 ± 0.58 × 106/g tissue
when digesting for 30 minutes using the combined enzymes
consisting of 0.1% collagenase IV, 0.1% dispase II and 0.05%
trypsin. With the prolonged digest, both cell yield and cell
death rate were increased (Table 1). When digesting time
was prolonged to 60 minutes, cell yield did not signiﬁcantly
increase compared with that of 45 minutes, but cell death
rate was signiﬁcantly increased (up to 13.12%, Figure 1(b)).
The highest viable cell yield was obtained at the digesting
time of 45 minutes (more than 107 cells/g tissue), while cell
viabilitywasmaintainedupto ∼91%.Thedatashowthatcell
yield was dramatically enhanced compared with previously
described method (Figure 1(a), P<. 01) by combining
collagenase IV, dispase II and trypsin for brown adipose
tissue digest.
3.2. High Cardiomyogenic Potential of Isolated Cells and
Cardiac Diﬀerentiation. To understand the characteristics of
stromal cells isolated from rat brown adipose, we analyzed
several surface markers with ﬂuorescence-activated cell sort-
ing (FACS) analyses (Figure 2,T a b l e2). The expression of
CD29, CD90 (suggested to be one of MSC markers), is
18.23±1.97% and 54.82±3.50%, respectively [21]. Most
of the cells were negative for CD45, a hematopoietic and
leukocyte marker. They also expressed negative for CD34, a
myeloid progenitor cell antigen present in endothelial cells
and some ﬁbroblasts too [22]. In addition, the percentage
of CD133-positive cells was up to ∼22.43%. Such cells
were conﬁrmed by the previous report [23]t od i ﬀerentiate
into cardiomyocytes with a high incidence. The percentage
is signiﬁcantly higher than the previous report [12, 23]
(which only obtained 3.5% CD133-positive cells in total
brown adipose-derived cells). Among the CD133 positive
cells, about 8.22±1.11% cells simultaneously express CD29.
After seeding on culture plates at diﬀerent densities,
cells adhered and proliferated, while cardiac stem cells
began to diﬀerentiate with prolonged culture. As shown in
Figure 3, around 6 days of culture, emergence of various4 Journal of Biomedicine and Biotechnology
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Figure 1: (a) Comparisons between diﬀerent methods in nucleated cell yield within one hour’s digest (n = 6 for each group). $: no signiﬁcant
diﬀerence, P>. 05; ∗: P<. 01 compared with all other groups in the same digest time. (b) Representative images of cell viability analysis.
Newly isolated cells from rat brown adipose were stained with Propidium iodide and then analyzed using ﬂow cytometry. A: Cell viability
after 30 minutes digestion with collagenase IV, dispase II, and trypsin; B: cell viability after 45 minutes digestion with collagenase IV, dispase
II, and trypsin; C: cell viability after 60 minutes digestion with collagenase IV, dispase II, and trypsin; D: Comparison of cell viabilities after
digesting for diﬀerent time with collagenase IV, dispase II, and trypsin, (n=6 for each group).Journal of Biomedicine and Biotechnology 5
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Figure 2: Representative images of ﬂow cytometry analyses for rat brown adipose-derived cells. Brown adipose-derived cells are partly positive
for CD-29, CD90, and CD133, while negative for CD45 and CD34. (a) Control; (b) Flow cytometry analysis for surface marker CD90; (c)
Flow cytometry analysis for surface marker CD29 and CD133; (d) Flow cytometry analysis for surface marker CD45; (e) Flow cytometry
analysis for surface marker CD34.
cell morphologies were identiﬁed, that is, ﬁbroblast-like
appearance, clusters of preadipocytes/adipocytes, and clones
of rounded cells together with small tube cells. At 1 week,
elongated cells appeared and started a contractile activity
independently. Following this, increasingly more elongated
morphology and contractile cells appeared with the time
(Figure 3). In 3 to 4 weeks, groups of contractile cells could
be seen in nearly any ﬁeld under an inverted phase-contrast
microscope. In the whole process, diﬀerentiation proceeded
spontaneously, using no inductor. However, the percentage
of beating cells counted at 3-4 weeks varied among the
seeding densities of isolated cells (details below).
3.3. CSC-Derived Cardiomyocytes Demonstrate Characteristic
Similar to Functional Cardiomyocytes
3.3.1. Expression of Cardiac Markers. In order to deﬁne the
phenotype of diﬀerentiated cells, immunoﬂuorescent stain-
ing of cardiac-speciﬁc antigens was performed on the slides
with elongated clusters of cells. In addition, the expression
of cardiac genes was analyzed by RT-PCR. As expected,
a speciﬁc positive staining was obtained with antibodies
against the sarcomeric α-actinin (Figure 4(a) A–C) and
cardiac troponin T (Figure 4(a) E–G); even the transverse
striation can be clearly observed (Figure 4(a) D, H). Some
elongated cells that do not contract under conditions could
also be stained by cTnT/α-actinin. In contrast, antibodies
against the skeletal muscle protein MyoD (data not show)
did not stain the elongated cells. The expressions of cTnI,
GATA4, Nkx2.5, MEF2C were also veriﬁed (Figure 4(b)).
T h e s ed a t as t r o n g l ya r g u e df o rt h ec a r d i o m y o c y t en a t u r eo f
the contracting cells.
3.3.2. Reaction with Pharmacologic Reagents. To test the
functionality of CSC-derived cardiomyocytes, pharmacolog-
ical studies were performed at 28 days after diﬀerentiation
of brown adipose-derived CSCs. Several pharmacologic
agents known to inﬂuence the heart rate were added
and the chronotropic responses of contracting cells to
these agents were examined. As expected for diﬀerenti-
ated cardiomyocytes, the β-agonist isoproterenol induced
a dose-dependent increase of the spontaneous contrac-
tion rate measured as beatings per minute (Figure 5).
Diltiazem, a nonselective β-adrenergic antagonist, reversed
the isoproterenol-induced acceleration (Figure 5). These
chronotropic responses deﬁnitively demonstrated that these
cells responded like functional cardiomyocytes. Note that
there was a great heterogeneity in the sensitivity to these
heartpharmacologicagentsamongdiﬀerentcardiomyocytes.
For instance, some cardiomyocytes that did not contract6 Journal of Biomedicine and Biotechnology
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Figure 3:Cultureanddiﬀerentiationofbrownadipose-derivedcardiacstemcells. Phase-contrastmicroscopyofdiﬀerentiated cardiomyocytes-
like cells at days 7, 14, and 28. Isolated primary cells were plated into culture dished (2.5 × 104 cells /cm2) and observed every day under an
inverted phase-contrast microscope at (a)–(c) 1 weeks after spontaneous diﬀerentiation, (d)–(f) 2 weeks after spontaneous diﬀerentiation,
(g)–(i) 4 weeks after spontaneous diﬀerentiation. Diﬀerentiated cells gradually increased in size with time due to cell proliferation. Early,
diﬀerentiated cells were rare in plates (day 7), then elongated cells appeared (day 14 and 28) more and more, and they could spontaneously
beat like functional cardiomyocytes (bar = 100μm).
Table 3: Comparison of diﬀerentiated cTnT+ cardiomyocytes (%) from brown adipose-derived cells at diﬀerent seeding densities.
Cell density 5 ×104/cm2 2.5 ×104/cm2 1 ×104/cm2 5 ×103/cm2 2.5 ×103/cm2 1 ×103/cm2
Combination∗ 24.78±2.4 29.93±3.2# 25.41±2.23 21.43±1.62 16.7±1.41 5.3±0.6
Dispase II∗ 11.64±1.98 15.43±2.76 12.35±2.21 9.64±2.55 5.7±1.24 2.41±0.91
∗Combination: cells isolated by combination of collgenase IV, dispase II, and trypsin; Dispase II: cells isolated by dispase II alone.
#The optimal seeding density for brown adipose-derived cardiac stem cells diﬀerentiation into cardiomyocytes (P<. 01,n = 6).
under control conditions started to beat under β-adrenergic
stimulation (data not shown). However, when cells were
responsive, similar pattern toward the drugs was also
observed.
3.4. Optimal Seeding Density for Cardiac Stem Cell Diﬀer-
entiation. The primary seeding density of brown adipose-
derived cells inﬂuences the diﬀerentiation eﬃciency of
cardiac stem cells into cardiomyocytes, as was demonstrated
in the previous report [12]. So correlation between seeding
density of primary cells and percentage of diﬀerentiated car-
diomyocytes was investigated to achieve the optimal cardiac
diﬀerentiation.AsshowninTable3,theappearanceofcTnT
+
CM cells varies from ∼5.3±0.6% to ∼29.93±3.2% with the
primary seeding densities increasing from 1 × 103/cm2–5 ×
104/cm2. These data showed that cells we isolated from
brown adipose by using this new method have even higher
cardiomyogenic potential than that previously reported [12].Journal of Biomedicine and Biotechnology 7
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Figure 4: (a) Immunostaining of diﬀerentiated cells for cardiac-speciﬁc antibodies. Diﬀerentiated cardiomyocytes-like cells were speciﬁcally
stained with antiα-sarcomeric actinin A–D, and anticardiac troponin A–I antibodies; the transverse striation can be clearly observed under
high magniﬁcation microcopy (D and I, 4 magniﬁcations of red frame in C and G, resp.). Furthermore, no speciﬁc staining was obtained
with the antiMyoD (data not shown) (Bar=50μm). (b) Expression of cardiac-speciﬁc genes in the diﬀerented cells analyzed by RT-PCR.
Note that no sorting procedure was performed in our study
(also diﬀerent from the previous report) [12].
4. Discussion
Heart disease is the leading cause of death in the industrial
world. The stem cell therapy seems to be a promising
treatment for injured myocardium. To reach this goal, it is
desirable to ﬁnd a good source of stem cells that can be
used to obtain new myocardium on time [21]. Several cell
types, for example, ESC, BMMSC, skeletal myoblasts, have
been considered candidates for myocardial regeneration.
However, each of them has shortfalls in clinical applications
[4–8]. The best candidates seem to be cardiac “progenitor”
and/or “stem” cells [21]. Currently the cardiac stem cell
transplantation for regenerating infarcted myocardium has
invited a great deal of interest. Many laboratories have
attempted to isolate potential cardiac stem cells from several
tissues [22]. In this study, we ﬁrstly combined collagenase
and dispase II with trypsin for brown adipose digestion
to isolate cardiac stem cells. Our main ﬁndings are the
following: (1) We established a new method to eﬃciently
isolate cells from rat brown adipose with a high content
of CSCs, and total cell yield increased up to more than
107/gram tissue. (2) We corroborated brown adipose to be
an abundant source of cardiac stem cells, useful for in vitro
studies of cardiomyocytes diﬀerentiation/(patho) physiology
and in vivo studies of cardiac stem cell therapy.
We demonstrated that a single collagenase or dispase
II was insuﬃcient for brown adipose digestion, leading
to relative lower cell yield (Figure 1(a)). However, when
collagenase was combined with dispase II supplemented
by trypsin, cell yield dramatically increased by manifolds
(Figure 1(a)). Eﬃcient tissue digestion was also observed.
I our experiment, tissue blocks also left undigested when
collagenase or dispase II was applied alone, albeit digesting
time extended to more than 2 hours (data not shown). In
contrast, tissue blocks could be hardly found in 30 minutes
digestion by combining three enzymes, indicating optimally
suﬃcient tissue digestion.
Several years ago, a single protease was demonstrated to
have limitations in digesting capacity when applied to digest
adipose tissues. Diﬀerent protease activity was necessary
for optimal tissue digest eﬃcacy and cell yield [19, 24–26].8 Journal of Biomedicine and Biotechnology
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Figure 5: Chronotropic response of contracting cells to adrenergic
and dilthiazem stimulation. Isolated cells were plated into 6-well
plate for 28 days. Basal beating rate was recorded. Contracting
rate was measured by the treatment with the β-adrenergic agonist
isoproterenolandantagonistdilthiazem.Resultsrepresentthemean
of 6 to 10 separate experiments.
However, the challenge is to balance the combination of
enzymes and digesting time for the desired cell yield
and function [27]. Additionally, it has been shown that
parameters (e.g., digest time and enzyme activity) applied
in the isolating procedure of primary cells have a signiﬁcant
eﬀect on cell yield, viability, and phenotype. Therefore,
isolating conditions were optimized. Isolated cells were also
evaluated for cardiomyogenic potential in our study. The
t i s s u ew a sd i g e s t e di n3 7
◦C, pH7.2–7.4, favorable for enzyme
activities. A magnetic stirrer was used to facilitate tissue
digestion. Under these conditions, optimal digesting time
w a sd e t e r m i n e dt ob e4 5m i n u t e s( t ob a l a n c et h et o t a lc e l l
yield and viability). When diﬀerentiating obtained cells into
cardiomyocytes, the isolated cells by this new method were
of high cardiomyogenic potential compared with what was
previously described [12]. Thus, this new method is proved
eﬃcient in total cell yield from brown adipose with high
cardiomyogenic potential. It is noteworthy that the method
is also suitable for multipotent stem cell isolation from rat
white adipose tissues (data not shown).
In consistency with the previous reports [12, 23], we
failed to get puriﬁed cardiac stem cells from brown adipose-
derived cell population. Thus a valid procedure for their
expansion in undiﬀerentiated states was not established. To
further their applications in cell therapies, a technique for
rapid puriﬁcation as well as a method of clinical grade
expansion for the cardiac stem cells is needed.
5. Conclusion
In this study, we have found an optimal combination of
digest enzymes consisting of 0.1% collagenase IV, 0.1%
dispase II, and 0.05% trypsin for eﬃcient isolation of cardiac
stem cells from brown adipose tissues. The procedure was
optimized for maximum viable cell yield (up to 107/cells
from 1 gram tissue sample). Furthermore, the obtained
cells could be eﬀectively diﬀerentiated into functional car-
diomyocytes. Therefore, we established a novel and eﬃcient
method for cardiac stem cell isolation from brown adipose.
It will pave the way for cardiac stem cell therapy as well as in
basic research.
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